Novel Blood Thinner Shows Promise in Atrial Fibrillation
TOPLINE: In the OCEANIC-AF trial, asundexian resulted in lower rates of stroke and bleeding than apixaban in patients with atrial fibrillation...
TOPLINE: In the OCEANIC-AF trial, asundexian resulted in lower rates of stroke and bleeding than apixaban in patients with atrial fibrillation...